跳至主要内容
临床试验/NCT05580224
NCT05580224招募中不适用

Anatomical Radiofrequency Ablation for Peripherally Located Small Hepatocellular Carcinoma Using Combined Energy Delivery Mode and Triple Cooled-Wet Electrodes

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 87 人开始时间: 2022年10月4日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
87
试验地点
1
主要终点
Technical success

研究概览

简要总结

The aim of this study is to investigate therapeutic outcomes of anatomical radiofrequency ablation for peripherally located small hepatocellular carcinoma using combined energy delivery mode and triple cooled-wet electrodes.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Child-Pugh class A or B
  • Presence of chronic hepatitis B or liver cirrhosis.
  • Patients with hepatocellular carcinomas diagnosed by histopathology or noninvasive imaging-based diagnosis according to the Korean Liver Cancer Association-National Cancer Center Korea guidelines.
  • Patients with viable hepatocellular carcinoma after locoregional treatment diagnosed by the Liver Imaging Reporting and Data System.
  • Tumor location is less than 5 cm from liver capsule.

排除标准

  • The number of tumor is three or more.
  • Tumor size is over 3 cm.
  • Tumor location is over 5 cm from liver capsule.
  • Child-Pugh class B8-9 or C.
  • Presence of macrovascular invasion and/or distant metastasis.
  • Platelet count < 50,000 mm3, or international normalized ratio > 1.5 (prothrombin time >1.5 × normal).

结局指标

主要结局

Technical success

时间窗: Immediately after radiofrequency ablation

Technical success addresses whether the index tumor was treated according to a predefined protocol and entirely covered by the ablation zone.

Local tumor progression rate

时间窗: 12 months after radiofrequency ablation

Local tumor progression, defined as the appearance of tumor foci at the margin of the ablation zone after the attainment of treatment success.

次要结局

  • Complication after radiofrequency ablation(Immediately, 1 month, 3 months, 6 months, 9 months, and 12 months after radiofrequency ablation)
  • Recurrence-free survival(12 months after radiofrequency ablation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jeong Min Lee

Professor

Seoul National University Hospital

研究点 (1)

Loading locations...

相似试验

Anatomical Radiofrequency Ablation for Small... | 临床试验